The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Network Pharmacology: A New Approach for Chinese Herbal Medicine Research
Open accessAbstract
The dominant paradigm of “one gene, one target, one disease” has influenced many aspects of drug discovery strategy. However, in recent years, it has been appreciated that many effective drugs act on multiple targets rather than a single one. As an integrated multidisciplinary concept, network pharmacology, which is based on system biology and polypharmacology, affords a novel network mode of “multiple targets, multiple effects, complex diseases” and replaces the “magic bullets” by “magic shotguns.” Chinese herbal medicine (CHM) has been recognized as one of the most important strategies in complementary and alternative medicine. Though CHM has been practiced for a very long time, its effectiveness and beneficial contribution to public health has not been fully recognized. Also, the knowledge on the mechanisms of CHM formulas is scarce. In the present review, the concept and significance of network pharmacology is briefly introduced. The application and potential role of network pharmacology in the CHM fields is also discussed, such as data collection, target prediction, network visualization, multicomponent interaction, and network toxicology. Furthermore, the developing tendency of network pharmacology is also summarized, and its role in CHM research is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Predicting new molecular targets for rhein using network pharmacology
Zhang, A., Sun, H. J., Yang, B., & Wang, X. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-20 · Cited by 47
RetractedData Mining: Practical Machine Learning Tools and Techniques
(2011) · Elsevier eBooks · doi:10.1016/c2009-0-19715-5 · Cited by 25,437
Error and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-L. (2000) · Nature · doi:10.1038/35019019 · Cited by 7,534
Error and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-Ĺ. (2000) · RePEc: Research Papers in Economics · Cited by 6,469
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Exploratory Social Network Analysis with Pajek: Revised and Expanded Edition for Updated Software
De Nooy, W., Mrvar, A., & Batagelj, V. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108565691 · Cited by 2,052
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Hopkins, A. L. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1110 · Cited by 1,242
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Yu, H., Kim, P. M., Sprecher, E., Trifonov, V., & Gerstein, M. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030059 · Cited by 1,014
The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes
Hillenmeyer, M. E., Fung, E., Wildenhain, J., Pierce, S. E., Hoon, S., Lee, W., Proctor, M., St.Onge, R. P., Tyers, M., Koller, D., et al. (2008) · Science · doi:10.1126/science.1150021 · Cited by 1,003
Variations in DNA elucidate molecular networks that cause disease
Chen, Y., Zhu, J., Lum, P. Y., Yang, X., Pinto, S., MacNeil, D. J., Zhang, C., Lamb, J., Edwards, S., Sieberts, S. K., et al. (2008) · Nature · doi:10.1038/nature06757 · Cited by 887 · cited 1×
“The drug discovery strategies thereby should explore the regulated pathology network and reduce the typically high attrition rates in the disease networks [19].”
BackgroundChen, C. Y.-C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015939 · Cited by 806
The efficiency of multi-target drugs: the network approach might help drug design
CSERMELY, P., AGOSTON, V, & PONGOR, S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.007 · Cited by 803
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Cytoscape Web: an interactive web-based network browser
Lopes, C. T., Franz, M., Kazi, F., Donaldson, S. L., Morris, Q., & Bader, G. D. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq430 · Cited by 721
Network‐based global inference of human disease genes
Wu, X., Jiang, R., Zhang, M. Q., & Li, S. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.27 · Cited by 660
SuperTarget and Matador: resources for exploring drug-target relationships
Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm862 · Cited by 647 · cited 1×
“In addition, the disease-drug-target databases such as SuperTarget, Matador [46], DrugBank [47], andTherapeutic Target Database [48] are also used for drug-target research on herbal compounds.”
BackgroundTao, W., Xu, X., Wang, X., Li, B., Wang, Y., Li, Y., & Yang, L. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.09.051 · Cited by 634
Target-based drug discovery: is something wrong?
Sams-Dodd, F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03316-1 · Cited by 522
The Comparative Toxicogenomics Database: update 2013
Davis, A. P., Murphy, C. G., Johnson, R., Lay, J. M., Lennon-Hopkins, K., Saraceni-Richards, C., Sciaky, D., King, B. L., Rosenstein, M. C., Wiegers, T. C., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks994 · Cited by 497
Cheung, F. (2011) · Nature · doi:10.1038/480s82a · Cited by 489
Surface plasmon resonance based biosensor technique: A review
Guo, X. (2012) · Journal of Biophotonics · doi:10.1002/jbio.201200015 · Cited by 436
Li, S., Zhang, B., & Zhang, N. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s10 · Cited by 380
Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network
Li, S., Zhang, Z. Q., Wu, L. J., Zhang, X. G., Li, Y. D., & Wang, Y. Y. (2007) · IET Systems Biology · doi:10.1049/iet-syb:20060032 · Cited by 366
HIT: linking herbal active ingredients to targets
Ye, H., Ye, L., Kang, H., Zhang, D., Tao, L., Tang, K., Liu, X., Zhu, R., Liu, Q., Chen, Y. Z., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1165 · Cited by 333
Traditional Chinese medicine in the Chinese health care system
Xu, J., & Yang, Y. (2009) · Health Policy · doi:10.1016/j.healthpol.2008.09.003 · Cited by 321
Li, S., Zhang, B., Jiang, D., Wei, Y., & Zhang, N. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s11-s6 · Cited by 275
Update of TTD: Therapeutic Target Database
Zhu, F., Han, B., Kumar, P., Liu, X., Ma, X., Wei, X., Huang, L., Guo, Y., Han, L., Zheng, C., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1014 · Cited by 274
Getting Closer to the Whole Picture
Sauer, U., Heinemann, M., & Zamboni, N. (2007) · Science · doi:10.1126/science.1142502 · Cited by 268
The Comparative Toxicogenomics Database: update 2011
Davis, A. P., King, B. L., Mockus, S., Murphy, C. G., Saraceni-Richards, C., Rosenstein, M., Wiegers, T., & Mattingly, C. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq813 · Cited by 235
Chen, X., Zhou, H., Liu, Y. B., Wang, J. F., Li, H., Ung, C. Y., Han, L. Y., Cao, Z. W., & Chen, Y. Z. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706945 · Cited by 226
Fakhari, F. D., & Dittmer, D. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6213-6223.2002 · Cited by 210
Flow cytometry for high-throughput, high-content screening
Edwards, B. S., Oprea, T., Prossnitz, E. R., & Sklar, L. A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.007 · Cited by 206
Biosensor-based small molecule fragment screening with biolayer interferometry
Wartchow, C. A., Podlaski, F., Li, S., Rowan, K., Zhang, X., Mark, D., & Huang, K. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9439-8 · Cited by 138
Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?
Wermuth, C. G. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03213-1 · Cited by 114
Metz, J. T., & Hajduk, P. J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.166 · Cited by 100
Li, B., Xu, X. J., Wang, X., Yu, H., Li, X., Tao, W., Wang, Y., & Yang, L. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013501 · Cited by 100
Li, S., Wu, L., & Zhang, Z. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl363 · Cited by 99
Hwang, W.-C., Zhang, A., & Ramanathan, M. K. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.129 · Cited by 95
Network target: a starting point for traditional Chinese medicine network pharmacology
Shao, L. (2011) · China Journal of Chinese Materia Medica · doi:10.4268/cjcmm20111502 · Cited by 88
Systems Biology—an interdisciplinary approach
Friboulet, A., & Daniel, T. (2005) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.11.014 · Cited by 86
Wang, X., Xu, X. J., Tao, W., Li, Y., Wang, Y., & Yang, L. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/519031 · Cited by 85
Farkas, I. J., Korcsmáros, T., Kovács, I. A., Mihalik, Á., Palotai, R., Simkó, G. I., Szalay, K. Z., Szalay-Bekő, M., Vellai, T., Wang, S., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001950 · Cited by 83
Gu, J., Zhang, H., Chen, L., Xu, S., Yuan, G., & Xu, X. (2011) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2011.07.003 · Cited by 77
Computer‐Aided Prediction of Rodent Carcinogenicity by PASS and CISOC‐PSCT
Lagunin, A. A., Filimonov, D. A., Zakharov, A. V., Xie, W., Huang, Y., Zhu, F., Shen, T., Yao, J., & Poroikov, V. (2009) · QSAR & Combinatorial Science · doi:10.1002/qsar.200860192 · Cited by 53
How to develop and use a Bayesian Belief Network.
Montironi, R., Whimster, W. F., Collan, Y. U., Hamilton, P. W., Thompson, D., & Bartels, P. H. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.3.194 · Cited by 37
Vitexicarpin Acts as a Novel Angiogenesis Inhibitor and Its Target Network
Zhang, B., Liu, L., Zhao, S., Wang, X., Liu, L., & Li, S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/278405 · Cited by 35
Study on TCM Syndrome Identification Modes of Coronary Heart Disease Based on Data Mining
Shi, Q. W., Zhao, H., Chen, J., Ma, X., Yang, Y., Zheng, C., & Wang, W. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/697028 · Cited by 35
Modeling drug action in the mouse with knockouts and RNA interference
Zambrowicz, B., & Sands, A. (2004) · Drug Discovery Today TARGETS · doi:10.1016/s1741-8372(04)02454-5 · Cited by 31
Web resources for drug toxicity
Wolfgang, G. H. I., & Johnson, D. E. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00022-7 · Cited by 30
Random network behaviour of protein structures
Brinda, K. V., Vishveshwara, S., & Vishveshwara, S. (2009) · Molecular BioSystems · doi:10.1039/b903019k · Cited by 27
Yan, J., Wang, Y., Luo, S.-J., & Qiao, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.04.057 · Cited by 20
Comparison and evaluation of network clustering algorithms applied to genetic interaction networks
Hou, L. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/532 · Cited by 2
Cited by
Network Pharmacology Approach for Medicinal Plants: Review and Assessment
Noor, F., Tahir ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S. S., & Aljasir, M. A. (2022) · Pharmaceuticals · doi:10.3390/ph15050572 · Cited by 540
Metadata
- Authors
- Zhang, G.-B., Li, Q.-Y., Chen, Q.-L., & Su, S.-B.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-9
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W2130303892
- Cited by
- 300
- References
- 59
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.